Nathan Pate

8PUBLICATIONS
70CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical infection agents (incl. prions)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 23, 2026
CD8 T-cell exhaustion linked with CAR T-cell failure can be mitigated by a non-alpha IL2 receptor agonist.

|May 02, 2026
HDAC Inhibition Unlocks Tumor Plasticity and Enhances Immunotherapy Response in Myc-Driven Small Cell Lung Cancer.

|Jan 26, 2024
Functional Heterogeneity in MET Pathway Activation in PDX Models of Osimertinib-resistant EGFR-driven Lung Cancer.

Nitin Roper, Rajaa El Meskini, Tapan Maity

|Aug 11, 2021
T Cell-Mediated Antitumor Immunity Cooperatively Induced By TGFβR1 Antagonism and Gemcitabine Counteracts Reformation of the Stromal Barrier in Pancreatic Cancer.

Dandan Li, Nicholas Schaub, Theresa M Guerin

|Jul 28, 2021
Novel Humanized Mesothelin-Expressing Genetically Engineered Mouse Models Underscore Challenges in Delivery of Complex Therapeutics to Pancreatic Cancers.

Brendan Hagerty, T Norene O'Sullivan, Xianyu Zhang

|Apr 23, 2021
Distinct Biomarker Profiles and TCR Sequence Diversity Characterize the Response to PD-L1 Blockade in a Mouse Melanoma Model.

Rajaa El Meskini, Devon Atkinson, Alan Kulaga

Pageof 2

Frequent Collaborators

3 joint publications

Devon Atkinson

3 joint publications

Zoë Weaver Ohler

3 joint publications

Udo Rudloff

2 joint publications

Rajaa El Meskini